These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10747836)

  • 1. Failure of oily chloramphenicol depot injection to treat plague in a murine model.
    Rahalison L; Guiyoule A; Bonacorsi SP; Slacanin I; Chanteau S; Carniel E
    J Antimicrob Chemother; 2000 Apr; 45(4):541-5. PubMed ID: 10747836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of resistance selection and mutant growth fitness on the relative efficacies of streptomycin and levofloxacin for plague therapy.
    Louie A; Deziel MR; Liu W; Drusano GL
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2661-7. PubMed ID: 17517837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic treatment of experimental pneumonic plague in mice.
    Byrne WR; Welkos SL; Pitt ML; Davis KJ; Brueckner RP; Ezzell JW; Nelson GO; Vaccaro JR; Battersby LC; Friedlander AM
    Antimicrob Agents Chemother; 1998 Mar; 42(3):675-81. PubMed ID: 9517950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathogenic properties of the toxin of Pasteurella pestis under the effect of some antibiotics. Protective and therapeutic effect of antibiotics in plague].
    Merinov SP; Vasil'eva ZI; Riabova GG
    Antibiotiki; 1970 Oct; 15(10):940-5. PubMed ID: 4321155
    [No Abstract]   [Full Text] [Related]  

  • 5. [Plague].
    Kamiyama T
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():453-8. PubMed ID: 12722261
    [No Abstract]   [Full Text] [Related]  

  • 6. [Determination of the sensitivity of the plague microbe to antibootics].
    Optiakova AF; Vorona IM; Minkov GB
    Zh Mikrobiol Epidemiol Immunobiol; 1967 Jan; 44(1):98-102. PubMed ID: 4302124
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro efficacy of antibiotics commonly used to treat human plague against intracellular Yersinia pestis.
    Wendte JM; Ponnusamy D; Reiber D; Blair JL; Clinkenbeard KD
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3752-7. PubMed ID: 21628541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Yersinia pestis and plague - an update].
    Stock I
    Med Monatsschr Pharm; 2014 Dec; 37(12):441-8; quiz 449. PubMed ID: 25643450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of a fluoroquinolone, three beta-lactams, two aminoglycosides, and a cycline in treatment of murine Yersinia pestis infection.
    Bonacorsi SP; Scavizzi MR; Guiyoule A; Amouroux JH; Carniel E
    Antimicrob Agents Chemother; 1994 Mar; 38(3):481-6. PubMed ID: 8203841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antimicrobial susceptibilities of strains of Yersinia pestis.
    Smith MD; Vinh DX; Nguyen TT; Wain J; Thung D; White NJ
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2153-4. PubMed ID: 8540736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial filamentation of Yersinia pestis by beta-lactam antibiotics in experimentally infected mice.
    Davis KJ; Vogel P; Fritz DL; Steele KE; Pitt ML; Welkos SL; Friedlander AM; Byrne WR
    Arch Pathol Lab Med; 1997 Aug; 121(8):865-8. PubMed ID: 9278616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous hypoxia reduces the concentration of streptomycin in the blood.
    Chen L; Gao Z
    BMC Infect Dis; 2018 Mar; 18(1):120. PubMed ID: 29523093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plague situation in the world].
    Kröger E
    Med Klin; 1970 Nov; 65(48):2135-40. PubMed ID: 5494645
    [No Abstract]   [Full Text] [Related]  

  • 14. [Evaluation of the effectiveness of antibacterial substances in treating an experimental form of bubonic plague in monkeys].
    Romanov VE; Evstigneev VI; Vasil'ev NT; Shabalin BA; Paramonov VE
    Antibiot Khimioter; 2001; 46(8):6-8. PubMed ID: 11871319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The sensitivity of plague agent from Siberian natural focuses of disease to antibacterial preparations in vitro].
    Balakhonov SV; Bel'kova SA; Tokmakova EG; Khvoĭnova IG; Zakhlebnaia OD
    Klin Lab Diagn; 2013 Apr; (4):36-40. PubMed ID: 23984554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of antibacterial therapy on the epidemic threat of experimental pneumonic plague in monkeys].
    Romanov VE; Vasil'ev NT; Shabalin BA; Mironin AV
    Antibiot Khimioter; 2001; 46(4):16-8. PubMed ID: 11550501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of antibody neutralization reaction for diagnosis of plague under conditions of streptomycin therapy].
    Aparin GP
    Antibiotiki; 1970 Jul; 15(7):626-9. PubMed ID: 4920968
    [No Abstract]   [Full Text] [Related]  

  • 18. Plague.
    Welty TK
    Am Fam Physician; 1986 Jun; 33(6):159-64. PubMed ID: 3716968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of monoclonal antibodies to plague microbe antigens at the early stage of infection in white mice for enhancement of the late streptomycin and doxycycline treatment].
    Ryzhko IV; Tsuraeva RI; Alekseeva LP; Shcherbaniuk AI; Mishan'kin MB
    Antibiot Khimioter; 2003; 48(3):21-5. PubMed ID: 12914117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Isepamycin in prophylaxis and treatment of experimental plague due to FI+ and FI- variants of plague microbe].
    Smorodinova IuV; Shcherbaniuk AI; Ryzhko IV; Moldavan IA
    Antibiot Khimioter; 2005; 50(8-9):23-6. PubMed ID: 17016907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.